Rockefeller Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Rockefeller Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-300	Closed	-$6K	–	4151
2022 Q4	$6K	Hold	300	–	–	﹤0.01%	3302
2022 Q3	$5K	Hold	300	–	–	﹤0.01%	3366
2022 Q2	$2K	Hold	300	–	–	﹤0.01%	3874
2022 Q1	$5K	Hold	300	–	–	﹤0.01%	3371
2021 Q4	$5K	Hold	300	–	–	﹤0.01%	3310
2021 Q3	$4K	Hold	300	–	–	﹤0.01%	3282
2021 Q2	$1K	Buy	+300	New	+$1.94K	﹤0.01%	3402
2019 Q1	–	Sell	-36,540	Closed	-$44K	–	1944
2018 Q4	$44K	Hold	36,540	–	–	﹤0.01%	537
2018 Q3	$86K	Hold	36,540	–	–	﹤0.01%	405
2018 Q2	$100K	Buy	+36,540	New	+$101K	﹤0.01%	381

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Rockefeller Capital Management's ISEE Position: Q1 2023 in Review

Rockefeller Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2023, closing a stake of 300 shares — an estimated $6K sold.

Rockefeller Capital Management first reported a position in ISEE in Q2 2018 and held it in 10 quarters. The position peaked at $100K in Q2 2018. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.

Rockefeller Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Rockefeller Capital Management sold 300 IVERIC bio, Inc. Common Stock shares in Q1 2023, an estimated $6K.
Rockefeller Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2018 and held it in 10 quarters.
Rockefeller Capital Management's IVERIC bio, Inc. Common Stock position peaked at $100K in Q2 2018.
223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.